West Pharmaceutical Services Inc (United States) is listed on the Nasdaq and has a market capitalization of $26.14 billion, with shareholders equity totaling $2.99 billion.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, West Pharmaceutical Services Inc reported $3.22 billion in revenue, generating net income of $542.70 million.
Key financial metrics include a P/E ratio of 48.16, a price-to-book (P/B) ratio of 8.74, and a trailing twelve-month dividend yield of 0.24%.
The company trades under the ticker WST.